Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $567.00 Price Target at Bank of America
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the pharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 16.97% from the company’s […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the pharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 16.97% from the company’s […]
